VRML Vermillion, Inc. gains 51% Mar 25, 2019
Posted On: Monday, March 25, 2019
Vermillion, Inc., together with its subsidiaries, discovers, develops, and commercializes diagnostic and bio-analytical solutions that help physicians to diagnose, treat, and enhance outcomes for women. It is developing novel diagnostic tests for gynecologic disease with focus on ovarian cancer. The company's lead in vitro diagnostic test is Overa, a blood test to aid physicians in pre-surgical assessment of ovarian tumors for malignancy, using an ialgorithmic approach. It serves clinical reference laboratories, hospital laboratories, and physician offices in the United States. Vermillion, Inc. was founded in 1993 and is headquartered in Austin, Texas.http://www.priceseries.com/trade/VRML-Vermillion-Inc-stock-gains-51-percent-a-Trade-Record-by-priceSeries-2019030620190325.html
SE Spectra Energy Corp gains 43% Mar 25, 2019
Posted On: Monday, March 25, 2019
Spectra Energy Corp owns and operates a portfolio of natural gas-related energy assets in North America. It operates through four segments: Spectra Energy Partners, Distribution, Western Canada Transmission & Processing, and Field Services. The Spectra Energy Partners segment engages in the transmission, storage, and gathering of natural gas, as well as transportation and storage of crude oil and natural gas liquids (NGLs) for customers in various regions of the United States and Canada. Its natural gas pipeline systems consist of approximately 21,000 miles of transmission pipelines; and storage capacity comprises 300 billion cubic feet (Bcf). The Distribution segment offers natural gas storage, transmission, and distribution services for residential, commercial, and industrial customers in Canada. It has approximately 40,000 miles of main and service pipelines; storage capacity of approximately 163 Bcf; and transmission system of approximately 3,000 miles of high-pressure pipeline and mainline compressor stations. The Western Canada Transmission & Processing segment provides natural gas transmission, and gas gathering and processing services; and services to natural gas producers to remove impurities from the raw gas stream, including water, carbon dioxide, hydrogen sulfide, and other substances. It also extracts, fractionates, transports, stores, and markets NGLs for western Canadian producers and NGL customers. It serves local distribution companies, end-use industrial and commercial customers, marketers, and exploration and production companies. The Field Services segment gathers, compresses, treats, processes, transports, stores, and sells natural gas; produces, fractionates, transports, stores, and sells NGLs; recovers and sells condensate; and trades in and markets natural gas and NGLs. It owns or operates approximately 67,000 miles of gathering and transmission pipeline. The company was incorporated in 2006 and is headquartered in Houston, Texas.http://www.priceseries.com/trade/SE-Spectra-Energy-Corp-stock-gains-43-percent-a-Trade-Record-by-priceSeries-2019022620190325.html
PM Philip Morris International Inc gains 23% Mar 25, 2019
Posted On: Monday, March 25, 2019
Philip Morris International Inc., through its subsidiaries, manufactures and sells cigarettes, other tobacco products, and other nicotine-containing products. Its portfolio of brands comprises Marlboro, Merit, Parliament, Virginia S., L&M, Philip Morris, Bond Street, Chesterfield, Lark, Muratti, Next, and Red & White. The company also owns various cigarette brands, such as Dji Sam Soe, Sampoerna, and U Mild in Indonesia; Champion, Fortune, and Jackpot in the Philippines; Apollo-Soyuz and Optima in Russia; Morven Gold in Pakistan; Boston in Colombia; Belmont, Canadian Classics, and Number 7 in Canada; f6 in Germany; Delicados in Mexico; Assos in Greece; and Petra in the Czech Republic and Slovakia. It markets and sells its products in the European Union, Eastern Europe, the Middle East, Africa, Asia, Latin America, and Canada. Philip Morris International Inc. was incorporated in 1987 and is based in New York, New York.http://www.priceseries.com/trade/PM-Philip-Morris-International-Inc-stock-gains-23-percent-a-Trade-Record-by-priceSeries-2019012520190325.html
OZM Och-Ziff Capital Management Group LLC gains 15% Mar 25, 2019
Posted On: Monday, March 25, 2019
Och-Ziff Capital Management Group LLC is a publicly owned hedge fund sponsor. The firm provides investment advisory services for its clients. It primarily caters to institutional investors which include pension funds, fund-of-funds, foundations and endowments, corporations and other institutions, private banks and family offices. The firm invests in equity and alternative markets across the world. It employs quantitative and qualitative analysis to make its investments. For its multi-strategy portfolios, the firm employs strategies like convertible and derivative arbitrage, corporate credit, long/short equity special situations, buyout investments, merger arbitrage, private investments, and structured credit. It also invests in real estate and traditional real estate assets including multifamily, office, hotel and retail, loans, portfolio acquisitions, loan pools, operating companies, structured debt products, public securities, and non-traditional real estate assets including gaming, distressed land and residential, cell towers, parking, golf, debt and senior housing. For private equity investments, it considers investments in a variety of special situations that seek to realize value through strategic sales or initial public offerings. The firm typically invests in the energy investments. It prefers to invest in United States. It also manages a buyout fund, Och-Ziff Energy Fund. Och-Ziff Capital Management Group LLC was founded in 1994 and is based New York City with additional offices in Houston, Texas, London, United Kingdom, Hong Kong, Tokyo, Japan, Bangalore, India, Singapore, and Beijing, China.http://www.priceseries.com/trade/OZM-Och-Ziff-Capital-Management-Group-LLC-stock-gains-15-percent-a-Trade-Record-by-priceSeries-2019030720190325.html
NEOS Neos Therapeutics, Inc. gains 24% Mar 25, 2019
Posted On: Monday, March 25, 2019
Neos Therapeutics, Inc., a pharmaceutical company, engages in the development, manufacture, and commercialization of products for the treatment of attention deficit hyperactivity disorder (ADHD) using its drug delivery technologies. Its product candidates are extended-release (XR) medications in orally disintegrating tablets or liquid suspension dosage forms. The company manufactures and markets generic Tussionex, a hydrocodone polistirex and chlorpheniramine polistirex XR liquid suspension product indicated for the relief of cough and upper respiratory symptoms associated with allergies or colds in adults and children of six years of age and older. Its product candidates include Adzenys XR-ODT amphetamine for the treatment of ADHD; Cotempla XR-ODT methylphenidate for the treatment of ADHD; and NT-0201 amphetamine XR liquid suspension for the treatment of ADHD. The company is headquartered in Grand Prairie, Texas.http://www.priceseries.com/trade/NEOS-Neos-Therapeutics-Inc-stock-gains-24-percent-a-Trade-Record-by-priceSeries-2019031320190325.html
NCTY The9 Limited gains 17% Mar 25, 2019
Posted On: Monday, March 25, 2019
The9 Limited, together with its subsidiaries, operates as an online game developer and operator in the People's Republic of China. The company offers online games, including massively multiplayer online games, mobile games, and TV games. It also provides training services, as well as operates mobile advertising platform. In addition, the company engages in the home entertainment set top box business. The company was formerly known as GameNow.net Limited and changed its name to The9 Limited in February 2004. The9 Limited was founded in 1999 and is headquartered in Shanghai, the People's Republic of China.http://www.priceseries.com/trade/NCTY-The9-Limited-stock-gains-17-percent-a-Trade-Record-by-priceSeries-2019031320190325.html
MYOK MyoKardia, Inc. gains 24% Mar 25, 2019
Posted On: Monday, March 25, 2019
Clinical-stage biotech developing therapies for heritable cardiomyopathies.http://www.priceseries.com/trade/MYOK-MyoKardia-Inc-stock-gains-24-percent-a-Trade-Record-by-priceSeries-2019021420190325.html
GRVY GRAVITY Co., Ltd. gains 35% Mar 25, 2019
Posted On: Monday, March 25, 2019
Gravity Co., Ltd. develops and publishes online games in South Korea, Japan, the United States, Canada, Taiwan, Hong Kong, Macau, China, and internationally. It offers online games; mobile games and applications; and other games and game-related products and services, including character-based merchandise and animation. The company's massively multiplayer online role playing games include Ragnarok Online, Ragnarok Online II, Requiem, Dragonica, and R.O.S.E. Online. It also provides console games and a game for Internet protocol television; and licenses the merchandizing rights of character-related products based on its online games. In addition, the company markets dolls, stationery, food, and other character-based merchandise, as well as game manuals, monthly magazines, and other publications. Further, it provides Website development and operation services; and sells goods related to mobile phones, such as ornamental accessories and USB data cables. The company was founded in 2000 and is headquartered in Seoul, South Korea. Gravity Co., Ltd. operates as a subsidiary of GungHo Online Entertainment, Inc.http://www.priceseries.com/trade/GRVY-GRAVITY-Co-Ltd-stock-gains-35-percent-a-Trade-Record-by-priceSeries-2019030120190325.html
GPN Global Payments Inc. gains 15% Mar 25, 2019
Posted On: Monday, March 25, 2019
Global Payments Inc. provides payment solutions for credit cards, debit cards, electronic payments, and check-related services. It operates in three segments: North America, Europe, and Asia-Pacific. The company's services include authorization services, settlement and funding services, customer support and help-desk functions, chargeback resolution, terminal rental, sales and deployment, payment security services, consolidated billing and statements, on-line reporting, industry compliance, and payment card industry security services. It also provides credit and debit card transaction processing services for various international card brands, including American Express, Discover Card, JCB, MasterCard, UnionPay International, and Visa; and non-traditional payment methods, as well as certain domestic debit networks, such as Interac in Canada. In addition, the company offers integrated commerce, omnichannel, vertically-oriented software, cloud-based point-of-sale, analytics, marketing, payroll, and other solutions; and ecommerce and omnichannel solutions through Realex Payments, a European online payment gateway technology, as well as gaming solutuions to licensed gaming operators. It serves customers in various industries comprising restaurant, hospitality, retail, convenience stores and petroleum, professional services, automotive, and lodging. The company markets its products and services through direct sales force, trade associations, agent and enterprise software providers, referral arrangements with value-added resellers, financial institutions, and independent sales organizations in 30 countries of North America, Europe, the Asia-Pacific region, and Brazil. Global Payments Inc. was founded in 1967 and is headquartered in Atlanta, Georgia.http://www.priceseries.com/trade/GPN-Global-Payments-Inc-stock-gains-15-percent-a-Trade-Record-by-priceSeries-2019020820190325.html
ADVM Adverum Biotechnologies, Inc. gains 16% Mar 25, 2019
Posted On: Monday, March 25, 2019
Avalanche Biotechnologies, Inc., a gene therapy company, engages in discovering and developing novel medicines that offer therapeutic benefit to patients suffering from chronic or debilitating disease. It primary focuses on developing AVA-101, which is in a Phase IIa trial for the treatment of wet age-related macular degeneration (AMD). The company is also developing AVA-201, a product candidate for the prevention of wet AMD; AVA-311 that is in preclinical studies for the treatment of juvenile X-linked retinoschisis, a rare genetic disease of the retina with no approved therapy; and AVA-322 and AVA-323 for the treatment of color vision deficiency. Avalanche Biotechnologies, Inc. has a collaboration agreement with Regeneron Pharmaceuticals, Inc. to research, develop, and commercialize gene therapy products. The company was founded in 2006 and is headquartered in Menlo Park, California.http://www.priceseries.com/trade/ADVM-Adverum-Biotechnologies-Inc-stock-gains-16-percent-a-Trade-Record-by-priceSeries-2019031120190325.html
Subscribe to:
Posts (Atom)










Popular
Tags
Videos